Angel Matthew
Transaction: 03/24/2026
BUY
Change
+231,482
Price
$2.16
Filing
06/23/2026
Type
BUY
Tempest Therapeutics, Inc.
TPST • Biotechnology
$1.03
▼ -0.02 (-1.90%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$16.14M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 2.5Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.03
Change-1.90%
Shares Out15.22M
Market Cap$16.14M
Enterprise Value$22.92M
52W Range0.84 - 12.23
Beta-1.68
P/E-0.40
P/B-14.80
P/FCF-1.56
EV/EBITDA-0.57
EV/FCF-2.21
Price$1.03
Change-1.90%
Shares Out15.22M
Market Cap$16.14M
Enterprise Value$22.92M
52W Range0.84 - 12.23
Beta-1.68
P/E-0.40
P/B-14.80
P/FCF-1.56
EV/EBITDA-0.57
EV/FCF-2.21
Earnings Yield-250.80%
FCF Yield-64.16%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq1.22
Current Ratio2.50
Quick Ratio2.50
Volume269.07K
Avg Volume222.10K
EPS Surprise-0.23
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
66/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
88/100
Why this score▼
Healthy liquidity · 2.5Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-04
90/100
Bullish
Bullish
4
Hold
1
Bearish
0
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Angel Matthew
Transaction: 03/24/2026
BUY
Change
+231,482
Price
$2.16
Filing
06/23/2026
Type
BUY
Yee John D.
Transaction: 06/04/2026
OTHER
Change
0
Price
Not reported
Filing
06/17/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Angel Matthew | BUY | +231,482 | $2.16 | 03/24/2026 | 06/23/2026 |
| Angel Matthew | BUY | +231,482 | $2.16 | 03/24/2026 | 06/23/2026 |
| Yee John D. | OTHER | 0 | Not reported | 06/04/2026 | 06/17/2026 |
| Yee John D. | BUY | +25,000 | $1.27 | 06/04/2026 | 06/17/2026 |
| Richey William Drake | BUY | +25,000 | $1.27 | 06/04/2026 | 06/08/2026 |
| Richey William Drake | OTHER | 0 | Not reported | 06/04/2026 | 06/08/2026 |
| Maestas Nicholas | BUY | +140,000 | $1.64 | 03/31/2026 | 04/02/2026 |
| Trojanowski Justin | BUY | +22,000 | $1.64 | 03/31/2026 | 04/02/2026 |
| Angel Matthew | BUY | +231,482 | $2.16 | 03/24/2026 | 03/25/2026 |
| Angel Matthew | BUY | +269,621 | $2.38 | 02/04/2026 | 02/06/2026 |
| Angel Matthew | OTHER | 0 | Not reported | 02/03/2026 | 02/06/2026 |
| Pellizzari Christine A | BUY | +1,230 | $2.94 | 01/27/2026 | 01/28/2026 |
| RAAB MICHAEL | BUY | +1,230 | $2.94 | 01/27/2026 | 01/28/2026 |
| NICHOL GEOFFREY | BUY | +1,230 | $2.94 | 01/27/2026 | 01/28/2026 |
| Simantov Ronit | BUY | +1,230 | $2.94 | 01/27/2026 | 01/28/2026 |
| Maestas Nicholas | BUY | +200,000 | $0.86 | 01/02/2025 | 01/06/2025 |
| Trojanowski Justin | BUY | +30,000 | $0.86 | 01/02/2025 | 01/06/2025 |
| Whiting Samuel | BUY | +270,000 | $0.86 | 01/02/2025 | 01/06/2025 |
| Brady Stephen R | BUY | +550,000 | $0.86 | 01/02/2025 | 01/06/2025 |
| Versant Venture Capital VI, L.P. | SELL | -387,999 | $1.10 | 08/12/2024 | 08/12/2024 |